Lucentis Intravitreal Injection 10 mg/mL, manufactured by Novartis Pharma, contains ranibizumab (genetical recombination). This solution for injection is indicated for eye diseases causing vision impairment, such as wet age-related macular degeneration, and is available as 0.5mg 0.05mL 1 bottle with YJ code 1319403A1036.
Lucentis Intravitreal Injection 10 mg/mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →